BiotequeROCO:4107 +0.87%84 FCF Margin % is 34.01% as of Dec. 2025, which is 49% above its 10-year median of 22.81. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.00 (Modestly Undervalued). Among 818 Medical Devices & Instruments companies, Bioteque ranks better than 96.82% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioteque's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$193 Mil. Bioteque's Revenue for the
three
months ended in Dec. 2025 was NT$567 Mil. Therefore, Bioteque's FCF Margin % for the quarter that ended in Dec. 2025 was 34.01%.
The historical rank and industry rank for Bioteque's FCF Margin % or its related term are showing as below:
ROCO:4107'
s FCF Margin % Range Over the Past 10 Years
Min: -4.47 Med: 22.81 Max: 31.18
Current: 28.41
During the past 13 years, the highest FCF Margin % of Bioteque was 31.18%. The lowest was -4.47%. And the median was 22.81%.
ROCO:4107's FCF Margin % is ranked better than 96.82% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: -0.375
vs ROCO:4107: 28.41
Bioteque FCF Margin % Related Terms
Bioteque FCF Margin % Historical Data
* Premium members only.
The historical data trend for Bioteque's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4107 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Bioteque's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioteque FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bioteque's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioteque (ROCO:4107) has a FCF Margin % of 34.01% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioteque and its competitors. This is 49% above median its historical median of 22.81. According to the industry distribution chart, Bioteque ranks #26 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 3.2%.
Is Bioteque's FCF Margin % too high?
Bioteque's current FCF Margin % of 34.01% is 49% above median its 10-year median of 22.81. Based on the distribution chart, Bioteque ranks #26 out of 818 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bioteque has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #26 out of 818 companies for FCF Margin %. This places Bioteque in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioteque and its competitors. Bioteque's current FCF Margin % is 34.01%, which is 49% above median its own 10-year median of 22.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.00, compared to a current price of NT$116.50 — trading 9.7% below its estimated fair value. The current FCF Margin % is 34.01%, which is 49% above median its 10-year median of 22.81. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current FCF Margin % is 34.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioteque (ROCO:4107) Overvalued in 2026?
Based on GuruFocus' analysis, Bioteque stock appears to be undervalued.
The current stock price of NT$116.50 is trading 9.7% below its estimated GF Value™ of NT$129.00.
GuruFocus considers Bioteque to be Modestly Undervalued.
Key valuation signals for ROCO:4107:
FCF Margin %: 34.01% (49% above median its 10-year median of 22.81)
GF Value™: NT$129.00 vs. price of NT$116.50 (9.7% below fair value)
No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score
Get the complete analysis for ROCO:4107
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4107 has been successfully added to your 
